Earnings Scheduled For February 8, 2022
Companies Reporting Before The Bell
• Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.
Keybanc Maintains Overweight on Steris, Raises Price Target to $256
Keybanc analyst Matthew Mishan maintains Steris (NYSE:STE) with a Overweight and raises the price target from $239 to $256.
Earnings Scheduled For November 2, 2021
Companies Reporting Before The Bell
• Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion.
Baird Maintains Outperform on Steris, Raises Price Target to $250
Baird analyst Mike Polark maintains Steris (NYSE:STE) with a Outperform and raises the price target from $230 to $250.
Stephens & Co. Maintains Overweight on Steris, Raises Price Target to $255
Stephens & Co. analyst Chris Cooley maintains Steris (NYSE:STE) with a Overweight and raises the price target from $217 to $255.
Keybanc Maintains Overweight on Steris, Raises Price Target to $239
Keybanc maintains Steris (NYSE:STE) with a Overweight and raises the price target from $227 to $239.
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 100 stocks hit new 52-week highs.
Steris Q1 Adj. EPS $1.76 Beats $1.51 Estimate, Sales $968.40M Beat $881.72M Estimate; Raises Guidance
Steris (NYSE:STE) reported quarterly earnings of $1.76 per share which beat the analyst consensus estimate of $1.51 by 16.56 percent. This is a 34.35 percent increase over earnings of $1.31 per share from the same period
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.